CRISPR screen identifies new regulator of androgen receptor in prostate cancer
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate cancer. In a systematic CRISPR screen, scientists from Arc Institute, UCSF, and the Fred Hutchinson ...
Nov 5, 2025
0
39









